Clin2
NCT06790095Worth exploringEnrolling by invitation

Testing Cyclosporine for Moderate to Severe Brain Injury

Traumatic Brain Injury

Treatments studied

Part of Brain & nervous system, Injuries & trauma clinical trials.

This study tests a drug called cyclosporine to see if it can help people with moderate to severe traumatic brain injury. You may be eligible if you have a brain injury seen on CT and can start treatment within 24 hours.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
26 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have a head injury and need a CT scan.
  • Your Glasgow Coma Scale score before any sedation was between 3 and 12 (this means you were not fully conscious).
  • A CT scan shows a brain bruise (contusion) or tiny blood vessel injury.
  • You can start the study treatment within 24 hours of the injury.
  • You do not have serious kidney, liver, or other diseases that would make the study unsafe.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04602806Enrolling by invitation
Precision medicine study for traumatic brain injury

This study is looking at people with traumatic brain injuries to improve how they are treated. If you join, you will get an MRI and other tests within the first two days after your injury, and the researchers will track your recovery over time.

San Francisco, California
NCT05826912Enrolling by invitation· Phase 2
Testing new treatment for acute brain injury after a fall or hit

This study tests an investigational treatment to improve outcomes after a recent non-penetrating traumatic brain injury (like a fall or car crash). It uses early CT/MRI imaging and a blood test soon after injury to see who benefits and how well the treatment works.

San Francisco, California
NCT07180277Recruiting· Phase 4
Steroid treatment for moderate to severe brain injury

This trial tests a steroid medicine called methylprednisolone to see if it can help people who have had a moderate to severe brain injury. It aims to reduce swelling in the brain and possibly improve recovery.

Suzhou, Jiangsu
NCT07358312Not yet recruiting
Steroids for brain swelling after head injury

This trial tests whether giving steroids can reduce brain swelling after a mild or moderate head injury. If you or a loved one had a brain injury within the last few days and the CT scan shows bruising, this study may offer extra treatment to help control swelling.

NCT06966713Recruiting
Predicting recovery after severe brain injury

This study looks at patients with severe traumatic brain injury (TBI) who already need brain pressure or oxygen monitoring. Doctors want to see if certain tests can help predict how well someone might recover.

Chicago, Illinois
NCT05337618Recruiting· Phase 2
Testing a medication approach to improve brain recovery after severe head injury

This Phase 2 trial is testing a combination medication strategy to improve outcomes after severe traumatic brain injury that needs emergency brain surgery soon after the injury. It may help by affecting how injured brain cells respond, aiming to improve survival or recovery.

Cincinnati, Ohio

Hear when a new Traumatic Brain Injury trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.